1014 related articles for article (PubMed ID: 11651755)
61. Psychosurgery in Massachusetts: a task force report.
Stone AA
Mass Journal Ment Health; 1975; 5(3):26-54. PubMed ID: 11664587
[No Abstract] [Full Text] [Related]
62. Regulatory aspects of the distinction between research and medical practice.
McCarthy CR
IRB; 1984; 6(3):7-8. PubMed ID: 11649567
[No Abstract] [Full Text] [Related]
63. Much more research to fall under IRB review.
Maloney DM
Hum Res Rep; 1999 Jul; 14(7):3. PubMed ID: 11658059
[No Abstract] [Full Text] [Related]
64. An IRB member's perspective on access to innovative therapy.
Moore DL
Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
[No Abstract] [Full Text] [Related]
65. Research involving children: an interpretation of the new regulations.
Levine RJ
IRB; 1983; 5(4):1-5. PubMed ID: 11649521
[No Abstract] [Full Text] [Related]
66. Testing drugs in pediatric populations: the FDA mandate.
Tauer CA
Account Res; 1999; 7(1):37-58. PubMed ID: 11657562
[No Abstract] [Full Text] [Related]
67. Hyperbaric research at Duke University--ethical considerations.
Bennett PB; Kylstra JA
Forsvarsmedicin; 1973; 9(3):373-8. PubMed ID: 11661280
[No Abstract] [Full Text] [Related]
68. Regulatory orphans: juvenile prisoners as transvulnerable research subjects.
Reed JG
IRB; 1999; 21(2):9-14. PubMed ID: 11657875
[No Abstract] [Full Text] [Related]
69. The NIH trials of growth hormone for short stature.
Tauer CA
IRB; 1994 May; 16(3):1-9. PubMed ID: 11659923
[No Abstract] [Full Text] [Related]
70. New policy on research with children is part of trend toward including more research subjects.
Maloney DM
Hum Res Rep; 1998 May; 13(5):1-2. PubMed ID: 11657189
[No Abstract] [Full Text] [Related]
71. Gene therapy in mental retardation: ethical considerations.
Fletcher JC
Ment Retard Dev Disabil Res Rev; 1995; 1():7-13. PubMed ID: 11660293
[No Abstract] [Full Text] [Related]
72. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
Prentice ED; Antonson DL; Leibrock LG; Kelso TK; Sears TD
IRB; 1993; 15(5):1-7. PubMed ID: 11659703
[No Abstract] [Full Text] [Related]
73. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
74. Proposed model federal policy for protection of human subjects; response to the First Biennial Report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research.
U.S. Office of Science and Technology Policy
Fed Regist; 1986 Jun; 51(106):20204-17. PubMed ID: 11658721
[No Abstract] [Full Text] [Related]
75. "Evaluation of human subject protections in schizophrenia research conducted by the University of ..." (Part III).
Maloney DM
Hum Res Rep; 2000 Jan; 15(1):5-6. PubMed ID: 11658036
[No Abstract] [Full Text] [Related]
76. Federal policy for the protection of human subjects. Final rule.
Fed Regist; 1991 Jun; 56(117):28003-18. PubMed ID: 10112214
[TBL] [Abstract][Full Text] [Related]
77. The history of institutional review boards.
Sherman M; Van Vleet JD
Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
[No Abstract] [Full Text] [Related]
78. Ethical considerations in human experimentation.
Bernstein JE
J Clin Pharmacol New Drugs; 1975; 15(8-9):579-90. PubMed ID: 11661224
[No Abstract] [Full Text] [Related]
79. An act...to establish a program of National Research Service Awards...and to provide for the protection of human subjects involved in biomedical and behavioral research.... Approved 12 Jul 1974.
U.S
US Statut Large; 1974; 88 342-354():2-354. PubMed ID: 12085916
[No Abstract] [Full Text] [Related]
80. Animal research: a call for legislative reform requiring ethical merit review.
Brody M
HELR Harvard Environ Law Rev; 1989; 13(2):423-84. PubMed ID: 11659214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
